CVS Health Stock News

CVS Health Corp (NYSE:CVS) ticked up in pre-market trading after announcing the addition of four board members as part of a deal with activist investor Glenview Capital Management.  Larry Robbins, chief executive of the hedge fund, will join CVS' board, alongside Leslie Norwalk, Guy Sansone, and Doug Shulman, leaving the company with 16 directors.

Hedge fund Glenview Capital Management has been advocating for improvements at the pharmacy and healthcare company.

CVS Health said on Monday it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund's chief executive Larry Robbins.

CVS Health Board of Directors appoints four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman Appointments follow productive engagement with Glenview Capital Management WOONSOCKET, R.I. , Nov. 18, 2024 /PRNewswire/ -- The Board of Directors of CVS Health (NYSE: CVS) today announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy Sansone, and...

Michigan's pension bought Palantir, Intel, and CVS Health stock, while slashing an investment in Bristol Myers in the third quarter.

Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing bets and established a new position during the third quarter, according to regulatory filings.

They're down, but they aren't out, at least not in the eyes of patient investors.

WOONSOCKET, R.I. , Nov. 11, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Wolfe 2024 Healthcare Conference on November 19, 2024, at approximately 10:20 am ET.